New route for tackling treatment-resistant prostate cancer

Scientists have identified a new treatment target for men with advanced prostate cancer that no longer responds to hormone therapy – a stage of the disease which usually proves lethal. They found that the protein paxillin regulates growth in advanced, castration-resistant prostate cancer cells – an important first step towards developing a treatment for men whose cancer prevails even after the most aggressive treatment.

Read the whole article on Science Daily

More from Science Daily